Gastro Quest is an interactive online module developed through a 3D anatomy and disease software platform. This module takes learners through an interactive journey of a specific disease state, highlighting disease progression, mechanism of action for therapeutic agents, and various treatment strategies.
Faculty:
Arthur J. DeCross MD AGAF
Professor of Medicine
Division of Gastroenterology and Hepatology
Director, Adult Gastroenterology, the Inflammatory Bowel Disease Center of URMC
University of Rochester Medical Center
Maisa I. Abdalla MD, MPH
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
University of Rochester Medical Center
Learning Objectives:
- Discuss IBD disease progression and factors for consideration when evaluating patient risk stratification.
- Analyze mechanism of action for current and emerging IBD therapeutic agents.
- Select appropriate, guideline recommended treatment strategies for IBD patients.
- Develop personalized care plans including long term treatment monitoring.
Disclosures
Arthur J. DeCross MD AGAF
- No financial relationship with an ineligible company
Maisa I. Abdalla MD, MPH
- No financial relationship with an ineligible company
Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: Sept. 29, 2024
